Science Corporation raises $400 million

Here you can read this post in these languages:

Science Corporation raises $400 million

Science Corporation, the medical technology startup founded by former Neuralink president Max Hodak in 2021, raised a $400 million Series D, the company said in a blog post. Investors in the new round valued the company at $3.5 billion. Backers included Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, and PLC Neurotech.

Hodak, who talked his way into a graduate neuroscience lab as a college student and has pursued biotechnology ever since, co-founded Science to leverage new technologies to understand and interact with the brain.

Science’s first product is PRIMA, a wearable and implantable chip that helps people with age-related macular degeneration recover some vision. The device is approved in Europe and available in Germany, and it is also being trialed for new conditions. Hodak announced onstage at TechCrunch Disrupt that the device is now being trialed for patients with Stargardt’s disease.

With the funding, the company aims to bring the device to the United States through the FDA’s Humanitarian Device Exemption, which allows experimental medical technology to be used to treat rare conditions. Science has convinced the FDA that advanced macular degeneration in both eyes is uncommon enough to seek approval to use the device on people in the US.

The startup’s long-term ambition is to connect directly to the human brain through a bio-hybrid sensor built from a combination of cultured neurons and silicon. The company is currently designing initial human trials of the device with Yale neurosurgery professor Murat Günel, who told TechCrunch it could offer potential treatments for Parkinson’s disease, among other brain injuries and illnesses.

Güncel Paylaşımlar

Related Posts

BİR YORUM BIRAK

Lütfen yorumunuzu giriniz!
Lütfen isminizi buraya giriniz